The Myeloid Transcription Factor KLF2 Regulates the Host Response to Polymicrobial Infection and Endotoxic Shock  by Mahabeleshwar, Ganapati H. et al.
Immunity
ArticleThe Myeloid Transcription Factor KLF2 Regulates
the Host Response to Polymicrobial Infection
and Endotoxic Shock
Ganapati H. Mahabeleshwar,1 Daiji Kawanami,1 Nikunj Sharma,1 Yoichi Takami,1 Guangjin Zhou,1 Hong Shi,1
Lalitha Nayak,1 Darwin Jeyaraj,1 Robert Grealy,2 Mary White,2 Ross McManus,2 Thomas Ryan,2 Patrick Leahy,3
Zhiyong Lin,1 Saptarsi M. Haldar,1 G. Brandon Atkins,1 Hector R. Wong,4 Jerry B. Lingrel,5 and Mukesh K. Jain1,*
1Case Cardiovascular Research Institute, Department of Medicine, Harrington-McLaughlin Heart and Vascular Institute, Case Western
Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
2Department of Anesthesia, Institute of Molecular Medicine, Trinity College Dublin, Dublin 8, Ireland
3Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA
4Division of Critical Care Medicine, Cincinnati Children’s Research Foundation and Department of Pediatrics
5Department of Molecular Genetics, Biochemistry and Microbiology
University of Cincinnati College of Medicine, Cincinnati, OH 45267-0524, USA
*Correspondence: mukesh.jain2@case.edu
DOI 10.1016/j.immuni.2011.04.014SUMMARY
Precise control of myeloid cell activation is required
for optimal host defense. However, this activation
process must be under exquisite control to prevent
uncontrolled inflammation. Herein, we identify the
Kruppel-like transcription factor 2 (KLF2) as a potent
regulator of myeloid cell activation in vivo. Exposure
of myeloid cells to hypoxia and/or bacterial products
reduced KLF2 expression while inducing hypoxia
inducible factor-1a (HIF-1a), findings that were reca-
pitulated in human septic patients. Myeloid KLF2
was found to be a potent inhibitor of nuclear factor-
kappaB (NF-kB)-dependent HIF-1a transcription
and, consequently, a critical determinant of outcome
in models of polymicrobial infection and endotoxe-
mia. Collectively, these observations identify KLF2
as a tonic repressor of myeloid cell activation in vivo
and an essential regulator of the innate immune
system.
INTRODUCTION
Cells of the myeloid lineage are the principal effectors of the
innate immune response to pathogen challenge. Under physio-
logic conditions, these cells circulate in the bloodstream in
a quiescent state. However, in response to an infectious stim-
ulus, these phagocytes are quickly activated and recruited to
sites of injury where they engage in the elimination of invading
microorganisms (Serbina et al., 2008; Serbina and Pamer,
2008). Indeed, myeloid cell activation is an exquisitely robust
biological response that involves transcriptional alterations in
gene expression affecting a substantial part of the cellular
genome (Kellam and Weiss, 2006). The transcriptional modules
that drive this response fashion the phagocyte with a multi-pronged armamentarium against invading microorganisms that
includes the elaboration of numerous antimicrobial peptides,
cytokines, chemokines, and reactive nitrogen and oxygen
species (Kolls et al., 2008). Successful containment of the path-
ogen typically leads to resolution followed by tissue repair.
However, if these initial efforts are unsuccessful, endotoxins
produced by the pathogen can lead to overexuberant activation
of phagocytes that can rapidly become deleterious to the host
(Gordon andMartinez, 2010; Martinez et al., 2009). This scenario
is seen clinically in the context of the host response to bacterial
infection (Munford, 2006). If successful containment is not
achieved, bacterial products such as lipopolysaccharides
(LPS) can lead to uncontrolled myeloid cell activation and culmi-
nate in a cytokine storm that leads to tissue damage, vascular
collapse, multiorgan failure, and death. These observations
suggest that although a robust myeloid response is necessary
for pathogen clearance, it can be detrimental to the host if left
unchecked. Thus, endogenous mechanisms must exist to
strictly maintain cell quiescence yet allow for rapid cellular acti-
vation with precise spatiotemporal control.
Because sites of bacterial infection are characterized by both
hypoxia and high amounts of bacterial products, there has been
intense interest in understanding how this microenvironment
induces myeloid cell activation. Elegant studies have identified
a synergistic and interdependent relationship between key tran-
scriptional pathways of the hypoxic and innate immune response
in governing myeloid cell activation—namely hypoxia-inducible
factor-1a (HIF-1a) and nuclear factor-kappaB (NF-kB) (Rius
et al., 2008). HIF-1 is a heterodimeric helix-loop-helix transcrip-
tion factor whose expression is tightly regulated at both the
mRNA and protein expression. The importance of HIF-1a in
myeloid cell biology isbest highlightedby loss-of-function studies
that show that HIF-1a is necessary formyeloid activation. Cramer
and colleagues demonstrated that HIF-1a-deficientmyeloid cells
exhibited reduced glycolysis and ATP production and a profound
impairment of cellular motility, invasiveness, and bacterial killing
(Cramer et al., 2003). Subsequent work from the same group
and others has verified the importance of HIF-1a in myeloid cellImmunity 34, 715–728, May 27, 2011 ª2011 Elsevier Inc. 715
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et al., 2005). Thesestudies also revealed that bacteria areapotent
stimulus for HIF-1a accumulation even under normoxic
conditions. Efforts to understand the molecular basis for this
observation led to an appreciation of an intimate and synergistic
relationship between HIF-1a and the NF-kB pathway (Nizet and
Johnson, 2009). HIF-1a has been shown to mediate NF-kB
activation in neutrophils and to promote the expression of
NF-kB-regulated proinflammatory cytokines (Walmsley et al.,
2005). Conversely, both hypoxia and bacterial products (e.g.,
LPS) induce HIF-1amRNA accumulation in an NF-kB-dependent
manner (Rius et al., 2008). This induction of HIF-1a mRNA is
a crucial precursor to the posttranscriptional stabilization and
accumulation of HIF-1a protein that occurs in the hypoxic micro-
environment. Thus, the combination of hypoxia and bacterial
products (e.g., LPS), as seen at sites of infection, can lead to
robust induction of the NF-kB-HIF-1a module, thereby resulting
inmyeloid cell activation (Nizet and Johnson, 2009). The intersec-
tion of NF-kB-HIF-1a signaling represents a key nodal point in
myeloid activation, so factors that inhibit this module might be
critical for maintenance of the quiescent state. In the current
study, we identify Kruppel-like factor 2 (KLF2) as such a factor.
Emerging evidence implicates the Kruppel-like factor (KLF)
family of zinc-finger transcription factors as endogenous regula-
tors of cellular activation (Cao et al., 2010). Kruppel-like factor 2
(KLF2) was initially identified and termed lung Kruppel-like factor
owing to its high expression in lung tissues (Anderson et al.,
1995). However, the in vivo role for this factor in the context of
myeloid cell biology has not been elucidated. Herein, we identify
myeloid KLF2 as an essential tonic repressor of myeloid cell acti-
vation. Furthermore, we provide evidence that KLF2-mediated
regulation of the NF-kB-HIF-1a axis titrates cellular activation
and is a critical determinant of the organism’s response to infec-
tion and endotoxic shock.
RESULTS
Myeloid-Specific KLF2 Deficiency Results
in Spontaneous Proinflammatory Activation
Myeloid-specific deletion of KLF2 was achieved through
crossing the Klf2fl/fl mouse to the Lyz2cre line. Extensive deletion
of KLF2 was observed in myeloid cells and no substantial effect
was seen on other major hematopoietic lineages, tissues, or
monocytic subsets (Figure S1 available online). Previous work
from our lab and others implicated KLF2 as a critical transcrip-
tion factor that maintains cellular quiescence (Bista et al.,
2008; Buckley et al., 2001; Dekker et al., 2006; SenBanerjee
et al., 2004). Therefore, we hypothesized that deficiency of
KLF2 may promote derepression of inflammatory cytokine
gene expression under noninflammatory conditions. Intriguingly,
basal expression of several proinflammatory cytokines was
induced significantly (p < 0.05) whereas anti-inflammatory cyto-
kines were unaltered (Figure 1A). These data suggest that KLF2
deficiency results in spontaneous myeloid cell activation.
Myeloid KLF2 Deficiency Is Protective against
Polymicrobial Infection
Activation of myeloid cells is requisite for optimal bactericidal
activity (Serbina and Pamer, 2008). As such, we hypothesized716 Immunity 34, 715–728, May 27, 2011 ª2011 Elsevier Inc.that the heightened basal activation observed in Lyz2cre Klf2fl/fl
mice may confer a greater capacity to withstand bacterial infec-
tion. To address this consideration, Lyz2cre and Lyz2cre Klf2fl/fl
mice were subjected to a polymicrobial infection by cecal
ligation and puncture (CLP) (Buras et al., 2005). As shown in
Figure 1B, survival of the Lyz2cre Klf2fl/fl mice was significantly
(p < 0.01) higher than that of Lyz2cre mice. Lyz2cre Klf2fl/fl
mice were also protected from polymicrobial infection-induced
hypotension and hypothermia (Figures 1C and 1D). Enumeration
of bacterial colonies from blood and homogenates of several
major organs revealed significantly lower (p < 0.05) colony-form-
ing units in Lyz2cre Klf2fl/fl mice (Figures 1E–1H). Consistent with
this reduction in bacterial colonization, Lyz2cre Klf2fl/fl mice
demonstrated moderately elevated expression of several proin-
flammatory cytokines (Figures 1I–1L). Collectively, these findings
indicate that myeloid-specific deficiency of KLF2 leads to
reduced bacterial burden and increased host survival in the
setting of polymicrobial infection.
KLF2 Deficiency Enhances Myeloid Cell
Bactericidal Activity
The reduced bacterial burden observed in Lyz2cre Klf2fl/fl mice
suggested that myeloid cells from these animals may exhibit
enhanced bactericidal capability. To test this directly, we
performed antibiotic protection assays (APA) in primary macro-
phages and neutrophils from Lyz2cre and Lyz2cre Klf2fl/fl mice.
As shown in Figures 2A and 2B, Lyz2cre Klf2fl/fl myeloid cells ex-
hibited significantly enhanced (p < 0.002) bactericidal capacity.
This effect was not due to an alteration in the rate of bacterial
uptake or phagocytosis as assessed by deconvolution micros-
copy (Figure S2A) and fluorescent activated cell sorting (FACS)
analysis (Figures S2B and S2C). In agreement with these loss-
of-function observations, adenoviral overexpression of KLF2 in
the RAW264.7 macrophage cell line significantly attenuated
(p < 0.00216) bactericidal capacity (Figures S2D and S2E).
Because KLF2 expression did not directly affect phagocytic
capacity, we focused attention on mechanisms of intracellular
pathogen killing. As shown in Figures 2C and 2D, KLF2-deficient
macrophages and neutrophils express significantly higher mRNA
encoding both CRAMP and iNOS, two agents with potent antimi-
crobial activity (p< 0.003). Consistent with these regulatory effects
on iNOS mRNA, parallel effects were observed for iNOS protein
accumulation andNOproduction (Figures 2E and 2F). Conversely,
overexpressionof KLF2 inRAW264.7 cells strongly attenuated the
LPS-induced upregulation of CRAMP and iNOSmRNA as well as
iNOS protein expression and activity (Figures S2F–S2I).
In addition to the elaboration of antimicrobial substances,
optimal myeloid cell function during inflammatory challenge
requires alterations in cellular metabolism (Krauss et al., 2001).
As shown in Figures 2G and 2H, KLF2 deficiency led to a signifi-
cant increase (p < 0.009) in LPS-induced glycolysis as evidenced
by higher lactate and intracellular ATP amounts. Furthermore,
enhanced expression of Glut1 and PGK were observed (Figures
2I and2J).Conversely, overexpressionofKLF2 inRAW264.7cells
led to a reduction in lactate production, ATP amounts, and Glut1,
PGKexpressionafter LPSstimulation (FiguresS2J–S2M).Collec-
tively, these results indicate that myeloid-specific deficiency of
KLF2 results in altered expression of antimicrobial andmetabolic
genes in a manner conducive to enhanced bactericidal activity.
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Figure 1. Myeloid KLF2 Deficiency Is Protective against Polymicrobial Infections
(A) Lyz2cre and Lyz2cre Klf2fl/fl mice plasma were obtain by retro-orbital bleeding and inflammatory cytokines were analyzed with MILLIPLEX MAP mouse
cytokine-chemokine panel from Millipore.
(B) Age- and sex-matched Lyz2cre and Lyz2cre Klf2fl/fl mice were subjected to CLP. These mice were observed for survival for 5 days.
(C and D) Age- and sex-matched Lyz2cre and Lyz2cre Klf2fl/fl mice were subjected to CLP and their average systolic blood pressure and core body temperature
measured after 24 hr of CLP.
(E–H) Blood, lung, liver, and kidney were collected from Lyz2cre and Lyz2cre Klf2fl/fl mice after 12 hr of sham or CLP procedure. Serial dilutions of these tissue
homogenate were plated on tryptic soya agar plates and enumerations of bacterial colony-forming units were indicated.
(I–L) Age- and sex-matched Lyz2cre and Lyz2cre Klf2fl/fl mice were subjected to sham or CLP procedure. Plasma of these mice was obtained by retro-orbital
bleeding and inflammatory cytokines were analyzed with MILLIPLEX MAP mouse cytokine and chemokine panel from Millipore.
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Tonic Repressor of Myeloid Cell ActivationMyeloid KLF2 Deficiency Renders Animals Susceptible
to Endotoxic Shock
Whereas increased inflammation can be advantageous in the
context of bacterial killing, unbridled inflammation can lead toseptic shock and death (Russell, 2006). We hypothesized that
Lyz2cre Klf2fl/fl mice, which are resistant to polymicrobial infec-
tion and exhibit a proinflammatory phenotype, might be more
susceptible to direct challenge with endotoxin. As shown inImmunity 34, 715–728, May 27, 2011 ª2011 Elsevier Inc. 717
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Figure 2. KLF2 Negatively Regulates Bactericidal Activity of Macrophages
(A and B) Peritoneal macrophages or neutrophils from Lyz2cre and Lyz2cre Klf2fl/fl mice were inoculated with E. coli at a MOI of 4 and intracellular bacterial killing
analyzed by antibiotic protection assay as described in Experimental Procedures.
(C and D) Primary peritoneal macrophages or neutrophils from Lyz2cre and Lyz2cre Klf2fl/fl mice were stimulated with 100 ng/ml LPS for 12 hr. CRAMP and iNOS
mRNA expression was analyzed by qPCR and normalized to 36B4.
(E and F) Peritoneal macrophages from Lyz2cre and Lyz2cre Klf2fl/fl mice were induced with 100 ng/ml LPS for 0–12 hr. Cell lysates were analyzed for expression
of iNOS by immunoblot. In a parallel experiment, cell culture supernatants after 20 hr of 100 ng/ml of LPS treatment were analyzed for nitrite concentration by
Griess assay as an index of iNOS activity.
(G and H) Lyz2cre and Lyz2cre Klf2fl/fl mice peritoneal macrophages were stimulated with 100 ng/ml LPS. Lactate concentration from these cell culture
supernatants and intracellular ATP concentration from cell lysates were quantified and normalized to total protein content.
(I and J) Lyz2cre and Lyz2cre Klf2fl/fl mice were stimulated with 100 ng/ml LPS. Total RNAwas isolated andmRNA expression of Glut-1 and PGKwas analyzed by
qPCR.
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Tonic Repressor of Myeloid Cell ActivationFigure 3A, LPS challenge of Lyz2cre Klf2fl/fl mice produced 100%
mortality by 72 hr, whereas Lyz2cremice experienced only 20%
mortality. In addition, Lyz2cre Klf2fl/fl mice exhibited all the718 Immunity 34, 715–728, May 27, 2011 ª2011 Elsevier Inc.cardinal features of endotoxic shock including hypothermia
(Figure 3B), hypotension (Figure 3C), and elevated shock index
(Figure 3D). By comparison to Lyz2cre mice, LPS-treated
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Figure 3. Myeloid KLF2 Is Protective against Endotoxemic Shock
(A) Age- and sex-matched Lyz2cre and Lyz2cre Klf2fl/fl mice were challenged with LPS (21 mg/kg). These mice were observed for 72 hr for survival.
(B–D) Age- and sex-matched Lyz2cre and Lyz2cre Klf2fl/fl mice were challenged with LPS (21 mg/kg) and monitored for changes in core body temperature,
systolic blood pressure, and shock index (SI = heart rate/systolic blood pressure).
(E–K) Age- and sex-matched Lyz2cre and Lyz2creKlf2fl/flmicewere challengedwith LPS (21mg/kg). Plasmawasobtained 4 hr after LPSor saline administrationby
retro-orbital bleeding. Inflammatory cytokines for the indicated factors were analyzed with MILLIPLEXMAPmouse cytokine and chemokine panel fromMillipore.
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Tonic Repressor of Myeloid Cell ActivationLyz2cre Klf2fl/fl mice had significantly elevated (p < 0.03)
amounts of plasma cytokines (Figures 3E–3K). Of note, the
amounts of many of these cytokines were dramatically higher
than that observed in the CLP studies and are consistent with
the fact that this model of LPS-induced endotoxic shock
produces a cytokine storm. Concordant effects were seen after
ex vivo stimulation of Lyz2cre and Lyz2cre Klf2fl/fl primarymacro-
phages with LPS (Figures S3A–S3K). Collectively, these results
strongly suggest that enhanced inflammation seen in the Lyz2cre
Klf2fl/fl mice is protective with respect to bacterial clearance but
detrimental in the face of direct endotoxin challenge.
Myeloid KLF2 Is Regulated by Hypoxia and Inflammatory
Stimuli
We next sought to understand the molecular mechanism that
rendered Lyz2cre Klf2fl/fl mice resistant to polymicrobial infectionand susceptible to LPS-induced endotoxemia. Intriguingly,
previous studies in the myeloid-specific gene ablation of
HIF-1a reported observations in contrast to those made in our
Lyz2cre Klf2fl/fl line. For example, myeloid deficiency of HIF-1a
has been shown to reduce myeloid cell probactericidal-proin-
flammatory gene expression, glycolysis (Cramer et al., 2003;
Peyssonnaux et al., 2005), and mortality in the face of an LPS
challenge (Peyssonnaux et al., 2007). Therefore, we focused
our attention on HIF-1a, a central integrator of both hypoxic
and innate immune stimulation in myeloid cells.
As a first step, the expression profile of KLF2 and HIF-1a in
wild-type primary peritoneal macrophages incubated with
heat-inactivated Gram-positive (S. aureus) or Gram-negative
(E. coli) extracts in combination with hypoxia was assessed. As
expected, HIF-1a expression was induced by both hypoxia-
and heat-inactivated extracts of Gram-positive or -negativeImmunity 34, 715–728, May 27, 2011 ª2011 Elsevier Inc. 719
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Figure 4. KLF2 Inhibits LPS-Induced NF-kB-Mediated HIF-1a Expression
(A) Wild-type primary peritoneal macrophages were exposed to heat-inactivated S. aureus or E. coli extracts in normoxic or hypoxic condition. Cell lysates were
analyzed for KLF2 and HIF-1a protein expression by immunoblotting.
(B) Whole blood-derived RNA was obtained from control and patients with septic shock and subjected to microarray analysis. Relative expression of KLF2 and
HIF-1a are indicated.
(C)Wild-typemice peritoneal macrophageswere stimulatedwith increasing dose of LPS for 8 hr. Cell lysates were subjected to immunoblot with HIF-1a antibody.
(D–F) RAW264.7 cells infected with Ad-GFP and Ad-KLF2 or primary peritoneal macrophages and neutrophils from Lyz2cre and Lyz2cre Klf2fl/fl mice were
stimulated with 100 ng/ml LPS. Total RNA was isolated and HIF-1a mRNA expression was analyzed by qPCR.
(G) RAW264.7 cells transfected with the HIF-1a promoter luciferase construct were cotransfected with KLF2 or NF-kB (p65) plasmid. These cells were stimulated
with LPS and cell lysates were analyzed for luciferase activity.
(H and I) RAW264.7 cells infected with Ad-GFP or Ad-KLF2 or primary peritoneal macrophages from Lyz2cre and Lyz2cre Klf2fl/fl mice were stimulated with LPS
for 1 hr. Chromatin immunoprecipitationwas performedwith the indicated antibody on theHIF-1a promoter containing theNF-kBbinding site at197/188 base
pairs.
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Tonic Repressor of Myeloid Cell Activationbacteria (Figure 4A; Figure S4B). A more robust induction of
HIF-1a was seen via dual stimulation of macrophages with
hypoxia and bacterial extracts. By contrast, KLF2 expression
was reduced by hypoxia and exposure to bacterial products at
the protein (Figure 4A) and mRNA expression (Figure S4A).
Because hypoxia has been shown to alter KLF2 expression in
a time-dependent fashion in endothelial cells (Kawanami et al.,
2009), we examined the kinetics of KLF2 expression in macro-
phages after hypoxia. Our results demonstrate that hypoxia
induces KLF2 expression at 1 hr followed by a marked reduction
in expression by 2 hr (Figure S4C). At later time points (6, 12, and
24 hr), KLF2 protein is essentially undetectable (Figure S4C).
Similar results were observed at the RNA expression (Fig-
ure S4D). Finally, we sought to understand the molecular basis
for how hypoxia reduced KLF2 expression. We note that
a previous publication from our lab showed that KLF2 expression
is negatively regulated by activation of NF-kB in the context of
cytokine stimulation (Kumar et al., 2005). In addition, a recent
report from Culver et al. (2010) demonstrated that hypoxia acti-
vates NF-kB and is a critical component of transcriptional
response to hypoxia. Therefore we hypothesized that NF-kB
may regulate KLF2 expression under hypoxic conditions. To
test this hypothesis, we exposed wild-type primary peritoneal
macrophages to hypoxia in the presence and absence of
a NF-kB-specific peptide inhibitor, SN-50. Hypoxia alone signif-
icantly reduced (p < 0.02) KLF2 expression in macrophages.
However, in the presence of SN-50, this reduction is strongly
attenuated at both the mRNA and protein expression (Figures
S4E and S4F).
Finally, to determine whether these changes in macrophage
KLF2 expression were observed in patients who were exposed
to bacterial infection and developed sepsis, whole blood-derived
RNA was generated from 98 patients with septic shock and 32
normal pediatric controls (Wong et al., 2009). As shown in Fig-
ure 4B, septic patients exhibited a significant reduction in
KLF2 and increase in HIF-1a mRNA expression (p < 0.002).
These data suggest that the expression pattern of KLF2 and
HIF-1a observed in cultured cells (Figure 4A) is recapitulated in
human sepsis.KLF2 Inhibits NF-kB-Mediated HIF-1a Expression
These observations prompted us to directly examine the role of
KLF2 in the molecular regulation of HIF-1a after LPS stimulation.
Consistent with previous reports (Blouin et al., 2004), LPS
induced HIF-1a protein accumulation (Figure 4C). Further, acti-
nomycin D studies confirmed that this induction was at the tran-
scriptional level (data not shown). KLF2 overexpression in
RAW264.7 cell line attenuated HIF-1a mRNA expression (Fig-
ure 4D) whereas Lyz2cre Klf2fl/fl macrophages and neutrophils
exhibited enhanced HIF-1a mRNA expression both at baseline
and after LPS stimulation (Figures 4E and 4F). To gain greater
insight into how KLF2 regulates HIF-1a mRNA, we undertook
gene reporter assays with a HIF-1a promoter-luciferase
construct. Recent studies indicate that NF-kB is a direct tran-(J) Basal expression of HIF-1a in Lyz2cre and Lyz2cre Klf2fl/fl mice peritoneal ma
(K and L) Primary peritoneal macrophages and neutrophils from Lyz2cre and Lyz2
for HIF-1a protein expression by immunoblot.scriptional regulator of HIF-1a (Rius et al., 2008). Therefore, we
hypothesized that KLF2 may reduce HIF-1a transcription via
inhibition of NF-kB activity. Indeed, KLF2 attenuated the ability
of p65 to induce the HIF-1a promoter under both basal and
LPS-stimulated conditions (Figure 4G). However, chromatin
immunoprecipitation (ChIP) studies revealed that neither overex-
pression nor deficiency of KLF2 altered p65 recruitment to the
endogenous HIF-1a promoter (Figures 4H and 4I). Thus, we
reasoned that the recruitment of key coactivators required for
optimal NF-kB activity may be affected by KLF2. Indeed, KLF2
overexpression attenuated and deficiency augmented recruit-
ment of critical NF-kB transcriptional coactivators p300 and
PCAF to the HIF-1a promoter (Figures 4H and 4I). A similar
conclusion was gleaned from studies on the expression of
IkBa, a well-established NF-kB target (Figure S4G). To gain
a more global understanding of KLF2 targets, we performed
Affymetrix microarray analyses with primary peritoneal macro-
phages from Lyz2cre and Lyz2cre Klf2fl/fl mice stimulated with
LPS for 6 hr. However, we note that, in addition to confirming
an increase in proinflammatory target genes (e.g., increase in
NOS2), the microarray revealed a number of novel targets rele-
vant to the inflammatory response (e.g., reduced expression of
anti-inflammatory targets such as arginase-1 [Arg-1] and resis-
tin-like molecule alpha [Retnla]). A subset of genes relevant to
inflammation is shown in Figure S4H.
Finally, to determine whether the effects of KLF2 on HIF-1a
mRNA translated into protein expression, immunoblot analyses
were performed. KLF2 deficiency enhanced basal and LPS-
stimulated increase in HIF-1a protein expression in primary
peritoneal macrophages and neutrophils (Figures 4J–4L).
Conversely, adenoviral overexpression of KLF2 in RAW264.7
cells strongly attenuated LPS-induced HIF-1a protein expres-
sion (Figure S4I). Collectively, these studies indicate that KLF2
negatively regulates LPS-induced HIF-1a expression through
modulating recruitment of critical coactivators of NF-kB to the
promoter of HIF-1a.Alterations in Lyz2cre Klf2fl/fl Myeloid Cell Gene
Expression and Function Are HIF-1a Dependent
We next sought to determine whether the proinflammatory
phenotype observed in Lyz2cre Klf2fl/fl mice was HIF-1a depen-
dent by using both pharmacologic and genetic approaches.
Echinomycin is a well-established inhibitor of HIF-1a (Kong
et al., 2005). As shown in Figures S5A and S5B, echinomycin
treatment strongly attenuated LPS-stimulated cell migration
and invasion in Lyz2cre Klf2fl/fl cells. Further, echinomycin
treatment also attenuated the LPS-induced hyperinduction of
numerous inflammatory gene products (Figures S5C–S5F),
glycolytic targets (Glut-1 and PGK), and metabolite markers of
glycolysis (lactate and ATP concenteration) (Figures S5G–S5J).
To substantiate the role of HIF-1a inhibition in vivo, we gener-
ated compound mutant mice in which both KLF2 and HIF-1a
(Lyz2cre Setd2fl/fl) were deleted in a myeloid-specific fashion
(termed Lyz2cre Klf2fl/flSetd2fl/fl). Dual deficiency of KLF2 andcrophages were analyzed by immunoblot.
cre Klf2fl/fl mice were stimulated with 100 ng/ml LPS. Cell lysates were analyzed
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Figure 5. Impaired Cellular Motility and Metabolism in KLF2-Deficient Macrophages Are HIF-1a Dependent
(A and B) Primary peritoneal macrophages from Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl mice were stimulated with 100 ng/ml LPS
and added to the upper chamber of a migration or invasion tissue culture insert. Cells were allowed to migrate for 18 hr and stained with Giemsa. The number of
control, unstimulated cells migrated or invaded across the membrane was assigned as 100% and fold changes over this are indicated.
(C–L) Primary peritoneal macrophages or neutrophils from Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl mice were stimulated with
100 ng/ml LPS. Total RNA was isolated and indicated target genes were analyzed by qPCR and normalized to 36B4. Expression of indicated genes in untreated
control peritoneal macrophages was set as 1.
(M andN) Peritoneal macrophages from Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl mice were stimulated with 100 ng/ml LPS. Lactate
concentration from these cell culture supernatant and intracellular ATP concentration from cell lysates were quantified and normalized to total protein content.
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(Figures S5K and S5L) and did not alter any hematologic param-
eters (Figures S1D, S1E, and S1K). Consistent with our observa-
tions via pharmacologic HIF-1a inhibition, genetic ablation of
HIF-1a completely rescued LPS-induced effects on cellular
migration and invasion observed in Lyz2cre Klf2fl/fl macrophages
(Figures 5A and 5B). Further, the heightened expression of
numerous gene products that are critically involved in various
aspects of macrophage biology such as COX2, ADM-1, MMP2,
TNF-a, IL-6, and IL-1bexpressionwasattenuatedbyHIF-1adefi-
ciency in Lyz2cre Klf2fl/fl macrophages (Figures 5C, 5E, 5G, 5I,
5K, and 5L). Concordant effectswere seen in neutrophils (Figures
5D, 5F, 5H, and 5J). Finally, analysis of glycolytic function after
LPS stimulation indicated that deficiency of HIF-1a in Lyz2cre
Klf2fl/fl macrophages also rescued enhanced glycolytic gene
expression andactivity as determinedbyGlut-1, PGKexpression
and lactate, intracellular ATPconcentration, respectively (Figures
5M–5P). Together, these results indicate that critical components
of the proinflammatory phenotype observed in KLF2-deficient
macrophages are HIF-1a dependent.
Response of KLF2-Deficient Mice to Infection
and Endotoxic Shock Are HIF-1a Dependent
We next sought to determine whether the HIF-1a dependency
observed in KLF2-deficient myeloid cells in ex vivo assays (Fig-
ure 5) was maintained in the intact organism. Examination of
basal plasma cytokine concenteration revealed that the
increased expression of several proinflammatory cytokines
seen in the Lyz2cre Klf2fl/fl mice was abrogated in Lyz2cre
Klf2fl/flSetd2fl/fl mice (Figure 6A). Next, we subjected Lyz2cre,
Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl
mice to both bacterial infection and endotoxic shock models.
As observed previously, Lyz2cre Klf2fl/fl mice were resistant to
polymicrobial infection and exhibited increased rates of survival
compared to control mice. Strikingly, dual deficiency of myeloid
KLF2 and HIF-1a (Lyz2cre Klf2fl/flSetd2fl/fl) rendered animals
highly susceptible to polymicrobial infection reaching 100%
mortality within 48 hr of CLP (Figure 6B). Enumeration of bacte-
rial culture from blood and tissue homogenates revealed that
myeloid deficiency of KLF2 significantly reduced the number of
live aerobic bacteria whereas the double-deficient KLF2 and
HIF-1a line (Lyz2cre Klf2fl/flSetd2fl/fl) had a significantly higher
(p < 0.03) number of live bacteria in the blood and peripheral
organs (Figures 6C and 6D; Figures S6A–S6C). Consistent with
this observation, deficiency of HIF-1a in Lyz2cre Klf2fl/fl macro-
phages significantly reduced (p < 0.002) bactericidal properties
observed in Lyz2cre Klf2fl/fl macrophages and was associated
with a 5-fold increase in survival of intracellular bacteria in
Lyz2cre Klf2fl/flSetd2fl/fl macrophages (Figure 6E). Analysis of
myeloid antimicrobial genes indicated that deficiency of HIF-1a
in Lyz2cre Klf2fl/fl macrophages and neutrophils resulted in
significantly attenuated (p < 0.02) expression of iNOS and
CRAMP after LPS stimulation (Figures 6F–6I).
Next, these same lines ofmicewere subjected to LPS-induced
endotoxemia. After LPS administration, Lyz2cre Klf2fl/fl mice(O and P) Peritoneal macrophages from Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl
RNA was isolated and Glut-1 and PGK mRNA expression was analyzed by qPCexhibited 100% mortality within 60 hr whereas the control line
exhibited only 50% mortality at 96 hr. By contrast, genetic defi-
ciency of HIF-1a in Lyz2cre Klf2fl/fl mice provided a potent
protective effect in the face of LPS-induced endotoxic shock
(as assessed by blood pressure and body temperature; Figures
6J and 6K) and mortality (Figure 6L). Analysis of circulating
plasma cytokines after LPS-induced endotoxemia indicated
that compound deficiency of HIF-1a and KLF2 significantly
(p < 0.002) attenuated plasma concenteration of several key
cytokines (Figures 6M–6P). These data are congruent with our
ex vivo studies (Figure 5) and demonstrate that the response of
Lyz2cre Klf2fl/fl mice to both polymicrobial infection and endo-
toxic shock are HIF-1a dependent.
DISCUSSION
The central finding of this study is that KLF2 inhibits
HIF-1a-dependent myeloid cell activation. Specifically, we find
that (1) KLF2 expression is regulated by hypoxia and bacterial
products in a manner that is antiparallel to that of HIF-1a, (2)
this antiparallel pattern of expression is recapitulated in human
subjects with sepsis, (3) KLF2 transcriptionally inhibits the
NF-kB-HIF-1 axis and attendant myeloid cell functions, (4)
myeloid deficiency of KLF2 confers a proinflammatory milieu
that offers protection in the context of polymicrobial infection
but is deleterious in the setting of LPS-induced endotoxic shock,
and (5) the phenotype of Lyz2cre Klf2fl/fl mice is rescued by
inhibition or ablation of HIF-1a. Collectively, these observations
identify KLF2 expression and function as a critical component
of the innate immune response to bacterial infection and endo-
toxic shock.
Our studies provide important insights regarding the role of
KLF2 as a transcriptional regulator of both myeloid cell quies-
cence and activation. On the basis of these observations, we
propose the model outlined in the graphical abstract, available
online. Circulatingmyeloid cells, which are in the quiescent state,
express robust levels of KLF2 and low expression of HIF-1a. As
a consequence, circulating concentration of proinflammatory
cytokines are held in check at vanishingly low levels. The impor-
tance of this basal KLF2 expression is underscored by the fact
that its deficiency leads to spontaneous activation of myeloid
cells—which is manifest as elevated serum concentration of
several proinflammatory cytokines in Lyz2cre Klf2fl/fl mice. Our
studies suggest that this modest increase in basal cytokines is
secondary to derepression of HIF-1a. In support, a modest but
appreciable increase in basal HIF-1a mRNA and protein are
observed in KLF2-deficient macrophages. Furthermore, the
increase in basal proinflammatory cytokines is completely abol-
ished by compound deficiency of KLF2 and HIF-1a.
Our studies also indicate that release from KLF2-mediated
repression is critical for optimal myeloid cell activation. Upon
egress into tissue, myeloid cells encounter hypoxic tissues as
well as foreign pathogens. Importantly, we find that both hypoxia
and bacterial products reduce KLF2 expression while robustly
activating HIF-1a expression and/or activity. These findings/fl, and Lyz2cre Klf2fl/flSetd2fl/fl mice were stimulated with 100 ng/ml LPS. Total
R and normalized to 36B4.
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Figure 6. Deficiency of HIF-1a Rescues Polymicrobial Infection and Endotoxic Shock Phenotypes in KLF2-Deficient Mice
(A) Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl mice plasma was obtained by retro-orbital bleeding and inflammatory cytokines
analyzed with MILLIPLEX MAP mouse cytokine and chemokine panel from Millipore.
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Tonic Repressor of Myeloid Cell Activationmay be clinically relevant, because a reduction in KLF2 mRNA
and enhanced HIF-1amRNA expression were seen in circulating
human myeloid cells from patients with sepsis. This reduction in
KLF2 expression appears to be required for optimal HIF-1a
activation, because sustained expression of KLF2 strongly
attenuates the NF-kB-mediated induction of HIF-1a mRNA and
protein. The coordinated reduction in KLF2 and induction of
HIF-1a allows for optimal bactericidal activity. Consistent with
this idea, KLF2-deficient myeloid cells are ‘‘primed’’ for activa-
tion in the basal state and exhibit robust bacterial killing in
antibiotic protection assays and confer improved survival after
CLP with reduced bacterial burden in blood and peripheral
tissues. The enhanced expression of HIF-1a observed in
KLF2-null cells is clearly an important mediator of the observed
phenotype, because myeloid cells deficient in both KLF2 and
HIF-1a lose bactericidal activity and succumb more readily after
CLP challenge. Our observations from the LPS-induced endo-
toxic shock experiments represent an extension of this line of
reasoning. In the event that initial host defense efforts fail, bacte-
rial products can leach out into the circulation and induce an
overwhelming inflammatory response. In this case, it is antici-
pated that KLF2 expression will fall in both circulating and
noncirculating myeloid cells, leading to an exaggerated induc-
tion of HIF-1a and an inflammatory storm. Consistent with this
model, Lyz2cre Klf2fl/fl mice exhibit a profound intolerance to
LPS-induced sepsis. Further, exceptionally high concentration
of cytokines (especially IL-1b, MCP-1, IL-17, and TNF-a) was
observed after LPS challenge, rendering animals unable to
sustain themselves against elevated concentration of bacterial
endotoxins. Again, the importance of HIF-1a in this setting is un-
derscored by the fact that Lyz2cre Klf2fl/flSetd2fl/fl mice exhibit
enhanced survival after LPS challenge. The latter finding is also
consistent with the observations of Peyssonnaux and colleagues
who demonstrated that myeloid HIF-1a deficiency renders
rodents resistant to LPS-induced sepsis (Peyssonnaux et al.,
2007). Collectively these studies identify a KLF2-HIF-1 axis as
critical in regulating the balance between myeloid quiescence
and activation.
Our mechanistic insights suggest that in the context of inflam-
matory stimuli such as LPS, KLF2’s ability to inhibit HIF-1a
expression occurs primarily through the inhibition of NF-kB-
dependent induction of HIF-1a mRNA expression. Our data
coupled with previous observations (Das et al., 2006; SenBaner-
jee et al., 2004) suggest that KLF2 does not affect the NF-kB
pathway at the cytosolic signaling or the recruitment of NF-kB(B) Survival of age- and sex-matched Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, a
for 5 days for their survival after CLP.
(C and D) Blood and lungs were collected from Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre S
Serial dilutions of blood and lung homogenate were plated on tryptic soya agar
(E) Peritoneal macrophages from Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and
intracellular bacterial killing analyzed by antibiotic protection assay.
(F–I) Primary peritoneal macrophages and neutrophils from Lyz2cre, Lyz2cre Klf
100 ng/ml LPS. Total RNA was isolated and both iNOS and CRAMP mRNA expr
(J–L) Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl micew
after LPS challenge.
(M–P) Age- and sex-matched Lyz2cre, Lyz2cre Klf2fl/fl, Lyz2cre Setd2fl/fl, and L
these mice were obtained 4 hr after LPS or saline administration by retro-orbital
MILLIPLEX MAP mouse cytokine-chemokine panel from Millipore.to the endogenous HIF-1a promoter. Intriguingly, the main effect
lies at the level of coactivator recruitment. Sustained expression
of KLF2 inhibits whereas deficiency augments p300 and PCAF
recruitment to the HIF-1a promoter. Previous studies by our
group and others reveal that KLF2 can interact directly with
both p300 and PCAF and thus, in the setting of sustained KLF2
expression, this probably constitutes the molecular basis for
preventing p300-PCAF recruitment to NF-kB (Ahmad and Ling-
rel, 2005; SenBanerjee et al., 2004). This type of control at the
target gene transcription is atypical and provides a particularly
elegant and important ‘‘molecular brake’’ that titrates the inflam-
matory transcriptional response. As KLF2 expression falls,
unbound p300-PCAF can more freely interact with NF-kB and
induce target genes. We note, however, that in the setting of
an infected tissue, HIF-1a expression are induced not only
through de novo transcription but also secondary to protein
stabilization. In this regard, a recent report by Kawanami and
colleagues showed that in hypoxic endothelial cells, KLF2 can
also reduce HIF-1a protein stability by disrupting interaction
with its chaperone Hsp90 (Kawanami et al., 2009). Whether
a similar mechanism is operative in hypoxic myeloid cells is an
important area for future investigation. Collectively, our observa-
tions along with previous work suggest that KLF2 negatively
regulates HIF-1a at both transcriptional and posttranscriptional
levels.
We note that although the survival phenotype observed in
myeloid KLF2-deficient animals supports a dominant role for
HIF-1a, there is evidence that additional mechanisms may also
be operative. For example, because myeloid deficiency of
HIF-1a, KLF2, and HIF-1a mice display similar rates of survival
in experimental models of sepsis, one may also expect minimal
differences in gene expression or functional responses in cell
and/or animals bearing these two genotypes. Although this
appears to be the case for many key myeloid genes functions,
several other parameters demonstrate differential responses
between the Lyz2cre Setd2fl/fl and Lyz2cre Klf2fl/flSetd2fl/fl geno-
types. Additionally, although much of our study highlights the
induction of proinflammatory targets after KLF2 depletion, our
microarrays also show reduced expression of numerous factors
with potent anti-inflammatory properties. These factors have
diverse cellular functions and include enzymes (e.g., arginase-
1 and TIMP3), growth factors (e.g., TGF-b superfamily
members), secreted molecules (e.g., Retnla and Cyr61), and
transcription factors (e.g., PPARd) (Barish et al., 2008; Gill
et al., 2010; Nair et al., 2009). We note that because ournd Lyz2cre Klf2fl/flSetd2fl/fl mice subjected to CLP. These mice were observed
etd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl mice after 12 hr of sham or CLP procedure.
plates and enumerations of bacterial colony-forming units were indicated.
Lyz2cre Klf2fl/flSetd2fl/fl mice were inoculated with E. coli at a MOI of 2 and
2fl/fl, Lyz2cre Setd2fl/fl, and Lyz2cre Klf2fl/flSetd2fl/fl mice were stimulated with
ession analyzed by qPCR and normalized to 36B4.
eremonitored for core body temperature, systolic blood pressure, and survival
yz2cre Klf2fl/flSetd2fl/fl mice were challenged with LPS (21 mg/kg). Plasma of
bleeding. Inflammatory cytokines for the indicated factors were analyzed with
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be underestimating the full spectrum of KLF2-regulated targets.
Indeed, kinetic microarray and/or RNA-seq approaches (Wang
et al., 2009) will be helpful toward gaining additional insights
regarding KLF2 action in myeloid biology. The importance of
these additional regulatory pathways will require additional
investigation and serve as the focus of future studies.
Finally, the observations presented in this study coupled with
previous studies of KLF2 biology bear important implications for
the clinical syndrome of sepsis. We note that the multiorgan
failure that typifies end-stage sepsis occurs not only through
exuberant myeloid cell activation but also secondary to wide-
spread endothelial damage (Aird, 2003). Characteristically,
endothelial injury in sepsis leads to diffuse vascular dysfunction
manifest as enhanced permeability, intravascular coagulation,
and loss of vascular tone (Schouten et al., 2008). A robust litera-
ture indicates that endothelial KLF2 is an essential regulator of
endothelial homeostasis (Atkins and Jain, 2007) and confers an
anti-inflammatory, antithrombotic, and antiadhesive phenotype
to the vessel wall (Dekker et al., 2006; Lin et al., 2005, 2006).
Indeed, KLF2+/ mice exhibit a proinflammatory (Atkins et al.,
2008) and propermeable vasculature (Lin et al., 2010). Collec-
tively, these observations along with findings presented in the
current study suggest that a reduction in endothelial andmyeloid
KLF2 expression may be functionally important in regulating the
organism’s response to sepsis. As such, manipulation of KLF2
expression may offer new opportunities for therapeutic gain.
Indeed, agents known to induce KLF2 expression such as statins
have been shown to ameliorate experimental sepsis and are
being considered for clinical application (Liappis et al., 2001).
EXPERIMENTAL PROCEDURES
Generation of Myeloid-Specific Deletion of KLF2 and HIF-1a Mice
Mouse line expressing lysozyme M promoter-driven Cre recombinase
(Lyz2cre) and HIF-1a floxed (Setd2fl/fl) mice were obtained from The Jackson
Laboratory. KLF2 floxed (Klf2fl/fl) mice were created in J.B.L.’s laboratory at
the University of Cincinnati as described before (Weinreich et al., 2009). Klf2fl/fl
mice were crossed with the Lyz2cre mice to generate myeloid-specific
KLF2-deficient mice. Similarly, Setd2fl/fl mice were crossed with Lyz2cre
mice to generate myeloid-specific HIF-1a-deficient mice. Finally, Lyz2cre
Klf2fl/fl and Lyz2cre Setd2fl/fl were crossed to generate KLF2 and HIF1a
myeloid-specific double-deficient mice. All mice colonies were maintained in
a clean animal facility and all animal experimentation was approved by the
Case Western Reserve University IACUC committee.
Bacterial Uptake and Killing Assay
E. coli was transformed with the GFP-expressing plasmid pTreacer-B. These
clones of bacteria were grown to logarithmic phase in Luria-broth medium (at
OD600, 0.4 = 10e8 cfu/ml). These bacterial cultures were pelleted, washed in
PBS, and diluted with DMEM supplemented with 0.1% BSA to desired
concentration. These live or inactivated bacteria were added to monolayer
of Lyz2cre, Lyz2cre Klf2fl/fl macrophages and RAW264.7 cells infected with
Ad-GFP or Ad-KLF2 to assess intracellular bacterial killing and cellular bacte-
rial uptake, respectively, as described before (Cramer et al., 2003).
Cecal Ligation and Puncture
CLP was performed as described before (Rittirsch et al., 2009). In brief, mice
were anesthetized and a midline incision was performed on abdominal side.
The cecum was exteriorized and ligature was placed at center of the cecum.
The ligated cecal stump was punctured twice with a 21-gauge needle and
small amount of stool was extruded. Next, the cecum was placed back into
its intra-abdominal position and abdomen closed with combination of running726 Immunity 34, 715–728, May 27, 2011 ª2011 Elsevier Inc.suture and stainless steel wound clips. All animals were subjected to postop-
erative fluid resuscitation with 1 ml prewarmed normal saline. After 12 hr of
CLP, rectal temperature and blood pressure were recorded. These mice
were anesthetized, blood collected by inferior vena cava injection, and lung,
liver, heart, and kidney were isolated and homogenized. Serial dilutions of
this homogenate were plated on tryptic soya agar plates for enumerations of
bacterial colony-forming units. For survival studies, a separate set of mice
was observed for 6 days after CLP. Survival data were analyzed by the
construction of Kaplan-Meier plots and use of the log-rank test.
LPS-Induced Endotoxic Shock
Mice (8–10 weeks old) were injected intraperitoneally with 21 mg/kg body-
weight of LPSor saline solution.Miceweremonitored for 8days after LPS injec-
tion and their rectal temperature, blood pressure, and heart beat rates were
recorded. Blood samples were drawn by retro-orbital bleeding on separate
set ofmice for cytokine analysis. Shock indexwas calculatedwith the following
formula: shock index = heart rate/systolic blood pressure. Survival data were
analyzed by the construction of Kaplan-Meier plots anduseof the log-rank test.
Quantification of Plasma Cytokines
Blood samples were collected after 4 hr of LPS or saline injection or 12 hr after
CLP or sham surgery by retro-orbital bleeding. Indicated mouse plasma were
analyzed with the MILLIPLEX MAP mouse cytokine or chemokine panel from
Millipore.
Real-Time Quantitative RT-PCR
Total RNA was extracted from primary macrophages, neutrophils, or
RAW264.7 cells after indicated treatment with TRIzol Reagent (Invitrogen)
and 2 mg of total RNA was reverse transcribed with M-MuLV reverse transcrip-
tase (New England Biolabs Inc.) and mixture of random and oligo-dT primers.
Real-time PCRwas performedwith Universal SYBRGreen PCRMaster Mix on
Applied Biosystems Step One Real-Time PCR System (Applied Biosystems)
with gene-specific primers.
Statistical Analysis
All data, unless indicated, are presented as the mean ± SD. The statistical
significance of differences between two groups was analyzed with Student’s
t test. Values of p < 0.05 were considered significant.
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